Farmakodynamika inhibítorov angiotenzín konvertujúceho enzýmu (ACEI)
[Pharmacodynamics of angiotensin-converting enzyme inhibitors]
Language Slovak Country Czech Republic Media print
Document type English Abstract, Journal Article
PubMed
8686197
- MeSH
- Angiotensin-Converting Enzyme Inhibitors pharmacology MeSH
- Blood Pressure drug effects MeSH
- Kidney drug effects MeSH
- Humans MeSH
- Renin-Angiotensin System drug effects MeSH
- Heart drug effects MeSH
- Check Tag
- Humans MeSH
- Publication type
- English Abstract MeSH
- Journal Article MeSH
- Names of Substances
- Angiotensin-Converting Enzyme Inhibitors MeSH
ACEI form a group of antihypertensives which inhibit the angiotensin II (A II) production and thus not only reduce the blood pressure but exert also a positive metabolic and antiproliferative effect (A II is a proliferative hormone). They are therefore indicated nowadays in the treatment of essential and secondary hypertension, left-ventricular hypertrophy, chronic heart failure, acute myocardial infarction, insulin resistance and other disorders. Despite intensive studies we still do not know many, in particular mediated effects, of ACEI but these drugs have become one of the key groups in therapy.